Searched for
MERCK RESEARCH LABORATORIES
Merck to partner with Google Cloud on AI initiativesDrugmaker Merck & Co is joining forces with Google Cloud. They will invest up to one billion dollars over several years. This partnership a...- Indian chip buzz catches the eye of specialty chemicals companiesMerck and Linde plan to set up specialty chemicals and gases facilities in India to support semiconductor manufacturing. Their investments ...
- Molnupiravir reduced Covid-linked hospitalisation by over 65%: StudyThe Phase III trial results of Hetero's Movfor (Molnupiravir), presented at the Conference on Retroviruses and Opportunistic Infections (CR...
- Covid antiviral drug Molnupiravir has 'major safety concerns', says ICMRFlagging the various health concerns surrounding the Covid anti-viral drug Molnupiravir, ICMR’s Dr Balram Bhargava said that Merck’s corona...
- Merck sees market for novel therapies, to focus on its oncology pipelineMerck is betting big on its oncology pipeline, in the field of immunotherapy that has come to define new-age cancer treatment.
- Hilleman Lab scouts for partners to develop low cost vaccinesHilleman said it is looking to tie up with vaccine specialty companies and government agencies to fund a Rs 300 project for developing some...
- Hilleman Lab to invest Rs 300 crore to develop vaccines"We are spending around Rs 300 crore over the next 4-5 years to develop low-cost vaccines. We are developing vaccines to treat rotavirus, c...
- Sun Pharma, Merck & Co Inc enter into pact for TildrakizumabUnder terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck.
- Symposium on new drug discovery begins at Zydus Research CentreThe symposium is to address various aspects related to new drug discovery with a focus on cancer, inflammation, cardiometabolic diseases an...
- Dr Reddy's, Merck to jointly develop biosimilarsmanufacturing of the compounds and will lead phase-III development.
- Hilleman Laboratories loses key executivesSome of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories.
- Hilleman Lab to invest about Rs 650 cr to develop vaccinesAs per the company's estimates, it will take 2-4 years in research and development activities to come out with the new vaccine.
- Merck, Ranbaxy drug development deal called offUS drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...
- Merck ends pact with RanbaxySeparate reports have said the world's 2nd largest drugmaker has now shifted the research programme to Aurigine, a wholly-owned drug discov...
- Merck to acquire SmartCells for USD 500 mnDrug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
- Merck may slash 15% of global workforce; shut research sitesGlobal healthcare major Merck & Co is planning to close 16 research and manufacturing sites worldwide and slash 15 per cent of its workforc...
- Ranbaxy enters into pact with Merck for anti-infective drugsRanbaxy Laboratories has signed a strategic product development agreement with German pharma major Merck for drug discovery and clinical de...
- Aurigene tech enters collaboration with Forest LabsThe company has also entered into a discovery collaboration with biotechnology company Merck Serono International
- PE majors woo Ranbaxy to fund Merck bidA host of international private equity funds are “hounding” Ranbaxy Laboratories with offers to fund the Indian pharmaceutical major’s bid ...
- Ranbaxy, Dr Reddy's get generic shotDrug majors Dr Reddy’s Laboratories (DRL) and Ranbaxy have scored a victory for their US businesses.
Load More
